Data for Naito, 2021, Combined Use of a Polycarboxybetaine Coating and a Selective Factor XII Inhibitor Markedly Reduces Artificial Surface Clot Formation While Preserving Normal Tissue Coagulation During Extracorporeal Life Support
Published: 20 January 2021| Version 1 | DOI: 10.17632/tg8dntkgsc.1
This data is in support of our study examining the combined use of polycarboxybetaine coatings and FXII inhibition during extracorporeal life support in rabbits.
Steps to reproduce
Please see paper by Naito N., Ukita R., et al.
Carnegie Mellon University College of Engineering
Biomedical Engineering, Critical Care, Extracorporeal Membrane Oxygenation, Extracorporeal Life Support